MarginsXMarginsX
Home › Markets › VXRT

Vaxart, Inc. (VXRT)

VXRT is quoted over the counter, not listed on an exchange. Vaxart, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.3600
-2.7% on the day
1-year return
-12.2%
Market cap
$87.7M
Micro cap. From the Nov 16, 2026 close × 243.7M shares (10-Q cover page, Oct 30, 2026)
P/E and P/S
3.0× · 0.5×
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerVXRT, quoted over the counter
SEC CIK0000072444
OTC Markets tierOTCQX (price source, 2026-11-13)
SEC industry codeBiological Products, (No Diagnostic Substances)
Business addressSouth San Francisco, CA
Incorporated inDE

Warning signs

Cash runway
Cash-flow positive
$35.1M cash at September 30, 2026
Share count, 1 year
+1.5%
2025-11-06 to 2026-10-30 · +60.3% over 3 years
Going-concern doubt
Yes
10-Q filed November 5, 2026
Insider net buying, 12 months
$31K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the date of the issuance of these unaudited condensed consolidated financial statements."
10-Q 2026-11-05
Cash and burn$35.1M cash; operating cash flow $8.2M a quarter.Report 2026-09-30
Shares outstanding243,702,034 (2026-10-30); 240,069,844 a year earlier; 152,038,840 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-05-04
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-11-21
AuditorWithumSmith+Brown, PC, San Francisco, California, United StatesPCAOB Form AP 2026-03-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $31K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$10.6M-$17.7M$1.4M$35.1MNo debt tags$181.3M10-Q 2026-11-05
Q2 2026
2026-06-30
$27.2M-$13.5M$2.8M$50.9MNo debt tags$243.1M10-Q 2026-08-06
Q1 2026
2026-03-31
$39.2M$5.2M-$2.1M$50.7MNo debt tags$255.6M10-Q 2026-05-07
Q4 2025
2025-12-31
$104.2M$55.0M$30.7M$53.8MNo debt tags$237.3M10-K 2026-03-13
Q3 2025
2025-09-30
$72.4M-$8.1M$2.6M$16.9MNo debt tags$148.2M10-Q 2026-11-05
Q2 2025
2025-06-30
$39.7M-$15.0M-$15.9M$20.1MNo debt tags$80.7M10-Q 2026-08-06
Q1 2025
2025-03-31
$20.9M-$15.6M-$9.6M$28.7MNo debt tags$47.4M10-Q 2026-05-07
Q4 2024
2024-12-31
$15.2M-$12.0M-$7.3M$25.2MNo debt tags$28.7M10-K 2026-03-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-05-19
Latest annual report10-K/A2026-04-30
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-07-06

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier